CompletedNot Applicable

Contribution of Hypnosis in Guided Hepatic Biopsy (Ap-Hy-PBH)

France70 participantsStarted 2022-09-29

Plain-language summary

The purpose of this study is to evaluate the contribution of hypnosis on the level of pain felt by the patient during ultrasound-guided hepatic biopsy, by comparing an intervention group (hypnosis) to a control group (routine and benevolent care). Single-center randomized controlled trial.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with an indication for ultrasound-guided hepatic biopsy * Over 18 years of age * Affiliated to a social security system Exclusion Criteria * History of psychiatric pathology, psychotropic or anxiolytic treatments * Refusal to participate. * People who do not understand and/or speak French. * People who are deaf * Patients with impaired cognitive abilities, evaluated by the prescribing service * Disorders of hemostasis against percutaneous approach * Allergy to Lidocaine * Patient under National Health Aids

What they're measuring

Difference between groups of pain level during ultrasound-guided hepatic biopsy.

Timeframe: day 1

Trial details

NCT IDNCT05413174

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-01

View on ClinicalTrials.gov More Ultrasound-guided Hepatic Biopsy trials